Phase 3 Glaucoma, Open-Angle Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
Glaucoma, Open-Angle
Glaukos Corporation230 enrolled1 locationNCT06066645
Recruiting
Phase 3
Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial
Glaucoma, Open-Angle
University College, London496 enrolled10 locationsNCT05405868
Recruiting
Phase 3
Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma
Glaucoma, Open-Angle
Omikron Italia S.r.l.1,000 enrolled1 locationNCT05710198
Recruiting
Phase 3
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
Ocular HypertensionGlaucoma, Open-Angle
Amneal Pharmaceuticals, LLC168 enrolled9 locationsNCT05401357